Correlation Between BioXcel Therapeutics and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both BioXcel Therapeutics and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioXcel Therapeutics and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioXcel Therapeutics and Biomarin Pharmaceutical, you can compare the effects of market volatilities on BioXcel Therapeutics and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioXcel Therapeutics with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioXcel Therapeutics and Biomarin Pharmaceutical.
Diversification Opportunities for BioXcel Therapeutics and Biomarin Pharmaceutical
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between BioXcel and Biomarin is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding BioXcel Therapeutics and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and BioXcel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioXcel Therapeutics are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of BioXcel Therapeutics i.e., BioXcel Therapeutics and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between BioXcel Therapeutics and Biomarin Pharmaceutical
Given the investment horizon of 90 days BioXcel Therapeutics is expected to under-perform the Biomarin Pharmaceutical. In addition to that, BioXcel Therapeutics is 4.2 times more volatile than Biomarin Pharmaceutical. It trades about -0.22 of its total potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.21 per unit of volatility. If you would invest 7,013 in Biomarin Pharmaceutical on August 28, 2024 and sell it today you would lose (504.00) from holding Biomarin Pharmaceutical or give up 7.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
BioXcel Therapeutics vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| BioXcel Therapeutics |
| Biomarin Pharmaceutical |
BioXcel Therapeutics and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioXcel Therapeutics and Biomarin Pharmaceutical
The main advantage of trading using opposite BioXcel Therapeutics and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioXcel Therapeutics position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| BioXcel Therapeutics vs. Terns Pharmaceuticals | BioXcel Therapeutics vs. Amylyx Pharmaceuticals | BioXcel Therapeutics vs. Acumen Pharmaceuticals | BioXcel Therapeutics vs. Inozyme Pharma |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |